These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34656399)

  • 21. Early experience with Levosimendan in children with ventricular dysfunction.
    Namachivayam P; Crossland DS; Butt WW; Shekerdemian LS
    Pediatr Crit Care Med; 2006 Sep; 7(5):445-8. PubMed ID: 16885788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery.
    Mehta RH; Leimberger JD; van Diepen S; Meza J; Wang A; Jankowich R; Harrison RW; Hay D; Fremes S; Duncan A; Soltesz EG; Luber J; Park S; Argenziano M; Murphy E; Marcel R; Kalavrouziotis D; Nagpal D; Bozinovski J; Toller W; Heringlake M; Goodman SG; Levy JH; Harrington RA; Anstrom KJ; Alexander JH;
    N Engl J Med; 2017 May; 376(21):2032-2042. PubMed ID: 28316276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levosimendan: a review of its use in the management of acute decompensated heart failure.
    Innes CA; Wagstaff AJ
    Drugs; 2003; 63(23):2651-71. PubMed ID: 14636085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous levosimendan treatment is cost-effective compared with dobutamine in severe low-output heart failure: an analysis based on the international LIDO trial.
    Cleland JG; Takala A; Apajasalo M; Zethraeus N; Kobelt G
    Eur J Heart Fail; 2003 Jan; 5(1):101-8. PubMed ID: 12559222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel biologic mechanisms of levosimendan and its effect on the failing heart.
    Parissis JT; Andreadou I; Bistola V; Paraskevaidis I; Filippatos G; Kremastinos DT
    Expert Opin Investig Drugs; 2008 Aug; 17(8):1143-50. PubMed ID: 18616411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndrome.
    Unverzagt S; Wachsmuth L; Hirsch K; Thiele H; Buerke M; Haerting J; Werdan K; Prondzinsky R
    Cochrane Database Syst Rev; 2014 Jan; (1):CD009669. PubMed ID: 24385385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of levosimendan on survival and adverse events after cardiac surgery: a meta-analysis.
    Harrison RW; Hasselblad V; Mehta RH; Levin R; Harrington RA; Alexander JH
    J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1224-32. PubMed ID: 24050857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Individualized use of levosimendan in cardiac surgery].
    Woehrle T; Mehringer L; Juchem G; Dashkevich A; Weis M; Schünemann M; Kilger E
    Anaesthesist; 2021 Mar; 70(3):204-212. PubMed ID: 33001236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levosimendan versus an intra-aortic balloon pump in adult cardiac surgery patients with low cardiac output.
    Elahi MM; Lam J; Asopa S; Matata BM
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):1154-62. PubMed ID: 21376634
    [No Abstract]   [Full Text] [Related]  

  • 30. Haemodynamic effects of levosimendan for low cardiac output after cardiac surgery: a case series.
    Malliotakis P; Xenikakis T; Linardakis M; Hassoulas J
    Hellenic J Cardiol; 2007; 48(2):80-8. PubMed ID: 17489345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levosimendan: a new inodilatory drug for the treatment of decompensated heart failure.
    Kivikko M; Lehtonen L
    Curr Pharm Des; 2005; 11(4):435-55. PubMed ID: 15725064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hemodynamic effects of levosimendan following cardiac surgery].
    Alvarez J; Taboada M; Rodríguez J; Caruezo V; Bouzada M; Campaña O; Bascuas B; Pérez-Paz J; Ginesta V
    Rev Esp Anestesiol Reanim; 2005; 52(7):389-94. PubMed ID: 16200918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levosimendan versus milrinone in neonates and infants after corrective open-heart surgery: a pilot study.
    Lechner E; Hofer A; Leitner-Peneder G; Freynschlag R; Mair R; Weinzettel R; Rehak P; Gombotz H
    Pediatr Crit Care Med; 2012 Sep; 13(5):542-8. PubMed ID: 22622649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass.
    Stocker CF; Shekerdemian LS; Nørgaard MA; Brizard CP; Mynard JP; Horton SB; Penny DJ
    Crit Care Med; 2007 Jan; 35(1):252-9. PubMed ID: 17133188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levosimendan for Hemodynamic Support after Cardiac Surgery.
    Landoni G; Lomivorotov VV; Alvaro G; Lobreglio R; Pisano A; Guarracino F; Calabrò MG; Grigoryev EV; Likhvantsev VV; Salgado-Filho MF; Bianchi A; Pasyuga VV; Baiocchi M; Pappalardo F; Monaco F; Boboshko VA; Abubakirov MN; Amantea B; Lembo R; Brazzi L; Verniero L; Bertini P; Scandroglio AM; Bove T; Belletti A; Michienzi MG; Shukevich DL; Zabelina TS; Bellomo R; Zangrillo A;
    N Engl J Med; 2017 May; 376(21):2021-2031. PubMed ID: 28320259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemodynamic effects of levosimendan in patients with low-output heart failure after cardiac surgery.
    Labriola C; Siro-Brigiani M; Carrata F; Santangelo E; Amantea B
    Int J Clin Pharmacol Ther; 2004 Apr; 42(4):204-11. PubMed ID: 15124978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of levosimendan in comparison and in combination with dobutamine in the treatment of decompensated heart failure.
    Cavusoglu Y
    Expert Opin Pharmacother; 2007 Apr; 8(5):665-77. PubMed ID: 17376021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First experiences with intraoperative Levosimendan in pediatric cardiac surgery.
    Osthaus WA; Boethig D; Winterhalter M; Huber D; Goerler H; Sasse M; Sümpelmann R
    Eur J Pediatr; 2009 Jun; 168(6):735-40. PubMed ID: 18813947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levosimendan, a new calcium-sensitizing inotrope for heart failure.
    Ng TM
    Pharmacotherapy; 2004 Oct; 24(10):1366-84. PubMed ID: 15628834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression.
    Morelli A; De Castro S; Teboul JL; Singer M; Rocco M; Conti G; De Luca L; Di Angelantonio E; Orecchioni A; Pandian NG; Pietropaoli P
    Intensive Care Med; 2005 May; 31(5):638-44. PubMed ID: 15812624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.